Tag: Cancer immunotherapy

Neoadjuvant Ipilimumab Nivolumab Melanoma Survival Biomarkers

January 28, 2026

Neoadjuvant Ipilimumab Nivolumab Melanoma Survival Biomarkers

Neoantigen Vaccine for Lynch Syndrome Cancer Prevention: Phase 1b/2 Trial Results

January 16, 2026

Neoantigen Vaccine for Lynch Syndrome Cancer Prevention: Phase 1b/2 Trial Results

Linavonkibart Pembrolizumab: Advanced Solid Tumors Trial

January 13, 2026

Linavonkibart Pembrolizumab: Advanced Solid Tumors Trial

Immune System Rejuvenation: MIT Study on Mice

December 20, 2025

Immune System Rejuvenation: MIT Study on Mice

Web Analytics